# Coridea NC1, Inc.: Form D filings

Coridea NC1, Inc., a biotechnology company in New York, NY, filed 3 Form D notices with the SEC between 2010 and 2012. The latest, on June 7, 2012, reports $5 million sold of a $10 million offering to 3 investors.

Find out what Coridea NC1, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Coridea%20NC1%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Coridea%20NC1%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcoridea-nc1-inc-1508105)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Coridea%20NC1%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Coridea%20NC1%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcoridea-nc1-inc-1508105)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: c/o G&L Consulting, LLC, 134 W. 26th Street, Suite 1011, New York, NY, 10001
- Phone: (212) 929-6600
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2010
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1508105

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 7, 2012 | New notice | $10,000,000 | $5,000,000 | $5,000,000 | 3 | May 25, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1508105/000150810512000001/0001508105-12-000001-index.htm) |
| Oct 17, 2011 | Amendment | $3,000,000 | $3,000,000 | $0 | 3 | Dec 13, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1508105/000150810511000001/0001508105-11-000001-index.htm) |
| Dec 17, 2010 | New notice | $1,500,000 | $1,000,000 | $500,000 | 3 | Dec 13, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1508105/000150810510000001/0001508105-10-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Jonathan S. Wyler | Director |  |
| Neil S. Exter | Director |  |
| Mitchell S. Bloom | Executive Officer |  |
| Mark R. Gelfand | Executive Officer |  |
| Howard R. Levin, M.D. | Executive Officer, Director |  |

## Other biotechnology companies in New York that filed recently

- [Swep Bio, Inc.](https://specstream.ai/data/form-d/company/swep-bio-inc-2159106) $2.5 million · Oct 29, 2026
- [Hypercell Technologies Inc.](https://specstream.ai/data/form-d/company/hypercell-technologies-inc-1882357) $3 million · Oct 14, 2026
- [CAD Therapeutics, Inc.](https://specstream.ai/data/form-d/company/cad-therapeutics-inc-2157566) $4 million · Oct 2, 2026
- [Vicora, Inc.](https://specstream.ai/data/form-d/company/vicora-inc-2091847) $2.3 million · Sep 18, 2026
- [GevRx Nutraceuticals, Inc.](https://specstream.ai/data/form-d/company/gevrx-nutraceuticals-inc-2156105) $300,000 · Sep 18, 2026
- [Episteme Prognostics, Inc.](https://specstream.ai/data/form-d/company/episteme-prognostics-inc-1902402) $5.1 million · Sep 4, 2026

[Every Form D from the week of Jun 4, 2012](https://specstream.ai/data/form-d/week/2012-06-04) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Coridea NC1, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).